Company
Apogee Therapeutics
Best-in-Class Therapies for Immunological and Inflammatory Diseases
Also known as Apogee Therapeutics, Inc
- Status
- Acquiredas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Philadelphia, PA, United States
- Founded
- 2022
- Legal name
- Apogee Therapeutics, Inc
- apogeetherapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 29 September 2026
About
Founded in 2022, Apogee leaders recognized that while existing drugs for certain inflammatory and immune diseases may work well, there is an opportunity to do better for patients – specifically, reducing the burden of frequent injections required in current treatment regimens by engineering and optimizing antibodies to be best in class, in order to improve the day-to-day lives of patients.
About the company
- Status notes
- APOGEE IS NOW PART OF ABBVIE!
Products
- Other
- APG279 (APG777 + APG990)
- Other
- ZUMILOKIBART (APG777)
Exit
- Acquisition
- 2026-09-03
Loading relationship preview